Dementia blood biomarkers in the context of post‐stroke cognitive outcomes: Systematic review and evidence synthesis
Alzheimer's & Dementia · 2026-07 · 22 (7)
DOI: 10.1002/alz.71653 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Alzheimer's & Dementia, online erschienen am 06.07.2026. Verfasst von Hing Tim Fung und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Brain Sciences, Imperial College London, London, UK. Hauptthemen laut MEDLINE: Biomarkers, Stroke, Dementia, Cognitive Dysfunction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Alzheimer's Society, British Heart Foundation, European Union's Horizon Europe research and innovation programme.
Themen: Demenz, Schlaganfall
Abstract (Originalsprache)
INTRODUCTION The prognostic value of emerging dementia‐related blood‐based biomarkers for post‐stroke cognitive impairment is poorly understood. We addressed this critical gap in this systematic review. METHODS Four databases were searched in March 2025 for studies of neurofilament light (NfL), glial fibrillary acidic protein (GFAP), amyloid beta (Aβ), tau, and placental growth factor (PlGF) in relation to post‐stroke cognitive outcomes. Risk of bias, narrative synthesis, and meta‐analysis were performed. RESULTS Eighteen studies were included, eleven assessing NfL. Meta‐analysis of four studies ( n = 2020) showed higher acute NfL was associated with worse cognition at 1–6 months ( Z = −0.518, 95% confidence interval [CI] −0.684 to −0.351). Baseline GFAP was associated with worse cognition longitudinally, whereas results for amyloid and tau species were inconsistent between studies. Risk of bias was high. DISCUSSION NfL and GFAP show the most consistent associations with post‐stroke cognition, particularly acutely. Evidence for amyloid and tau was inconsistent between studies, and PlGF remains unexplored.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Brain Sciences, Imperial College London, London, UK.
- Imperial College Healthcare NHS Trust, London, UK.
- UK Dementia Research Institute Centre, Imperial College London, London, UK.
- Rosalind Franklin Institute, Didcot, UK.
- School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
- Geoffrey Jefferson Brain Research Centre, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
Förderung
- Alzheimer's Society
- British Heart Foundation
- European Union's Horizon Europe research and innovation programme
- Medical Research Council (MRC)
- National Institute for Health and Care Research (NIHR)
- Swedish Research Council
- Swedish State Support for Clinical Research
- UK Dementia Research Institute
Zitieren
APA
Fung, H. T., Burton, O., Bortnowschi, M., Matthews, P. M., Parkes, L. M., Zetterberg, H., Hainsworth, A. H., & Geranmayeh, F. (2026). Dementia blood biomarkers in the context of post‐stroke cognitive outcomes: Systematic review and evidence synthesis. Alzheimer's & Dementia, 22(7). https://doi.org/10.1002/alz.71653
Vancouver
Fung HT, Burton O, Bortnowschi M, Matthews PM, Parkes LM, Zetterberg H, et al. Dementia blood biomarkers in the context of post‐stroke cognitive outcomes: Systematic review and evidence synthesis. Alzheimer's & Dementia. 2026;22(7). doi:10.1002/alz.71653
BibTeX
@article{Fung2026,
author = {Fung, Hing Tim and Burton, Olivia and Bortnowschi, Mara and Matthews, Paul M and Parkes, Laura M and Zetterberg, Henrik and Hainsworth, Atticus H and Geranmayeh, Fatemeh},
title = {Dementia blood biomarkers in the context of post‐stroke cognitive outcomes: Systematic review and evidence synthesis},
journal = {Alzheimer's & Dementia},
year = {2026},
volume = {22},
number = {7},
doi = {10.1002/alz.71653}
}
EUVIMED